Clinical Trials Browser

Phase 2 × Nasopharyngeal Carcinoma × famitinib × Clear all

NCT01392235 2019-01-22

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

Nasopharyngeal Carcinoma